Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery

Published:2014-04-18 Issue:23 Volume:35 Page:1510-1514
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:European Heart Journal

Author:

Sousa-Uva M.,Storey R.,Huber K.,Falk V.,Leite-Moreira A. F.,Amour J.,Attar N. A.-,Ascione R.,Taggart D.,Collet J.-P.,

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/35/23/1510/17354383/ehu158.pdf

Reference89 articles.

1. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting*

2. The way I see it: House officers need formal career development

3. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease

4. Starting aspirin therapy after operation. Effects on early graft patency. Department of Veterans Affairs Cooperative Study Group.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2024 ESC Guidelines for the management of chronic coronary syndromes;European Heart Journal;2024-08-30

2. Comparative effectiveness of antiplatelet therapies for saphenous venous graft occlusion and cardiovascular outcomes: a network meta-analysis;Minerva Cardiology and Angiology;2024-08

3. Coronary bypass surgery for multivessel disease after percutaneous coronary intervention in acute coronary syndromes: why, for whom, how early?;European Heart Journal;2024-07-26

4. Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial;BMJ;2024-06-11

5. Ticagrelor inverse agonist activity at the P2Y₁₂ receptor is non‐reversible versus its endogenous agonist adenosine 5´‐diphosphate;British Journal of Pharmacology;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3